TRIALMED Trademark

Trademark Overview

On Friday, September 13, 2024, a trademark application was filed for TRIALMED with the United States Patent and Trademark Office. The USPTO has given the TRIALMED trademark a serial number of 98750608. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, September 13, 2024. This trademark is owned by Synexus Clinical Research US, Inc.. The TRIALMED trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical research and scientific analysis in the field of pharmaceutical drugs, medical devices, and clinical trials
trialmed

General Information

Serial Number98750608
Word MarkTRIALMED
Filing DateFriday, September 13, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, September 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesClinical research and scientific analysis in the field of pharmaceutical drugs, medical devices, and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 13, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSynexus Clinical Research US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, NC 28401

Trademark Events

Event DateEvent Description
Friday, September 13, 2024NEW APPLICATION ENTERED
Friday, September 20, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, September 20, 2024TEAS VOLUNTARY AMENDMENT RECEIVED

Related Keywords

trialmed clinical medical devices trials drugs field research scientific analysis pharmaceutical